|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Bridget WagnerPublisher: Humana Press Inc. Imprint: Humana Press Inc. Edition: Softcover Reprint of the Original 1st 2018 ed. Volume: 1787 Weight: 0.559kg ISBN: 9781493993031ISBN 10: 1493993038 Pages: 280 Publication Date: 10 December 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsNutrient Stress Small-Molecule Screening Platform for Escherichia coli.- Validation and Development of an Escherichia coli Riboflavin Pathway Phenotypic Screen Hit as a Small-molecule Ligand of the Flavin Mononucleotide Riboswitch.- Phenotypic Screening of Small Molecules with Anti-malarial Activity for Three Different Parasitic Life Stages.- Phenotypic Screening for Inhibitors of a Mutant Thrombopoietin Receptor.- A cell-based Assay for Mitotic Spindle Orientation.- Isolation of Skeletal Muscle Stem Cells for Phenotypic Screens for Modulators of Proliferation.- Cell-based Methods to Identify Inducers of Human Pancreatic Beta-cell Proliferation.- High-content Imaging Phenotypic Screen for Neurogenesis Using Primary Neural Progenitor Cells.- Discovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments.- The Ancient Genetic Networks of Obesity: Whole-animal Automated Screening for Conserved Fat Regulators.- Modulation of Threat Response in Larval Zebrafish.- A PLA-iRoCS Pipeline for the Localization of Protein-Protein Interactions in situ.- High-Dimensional Profiling: The Theta Comparative Cell Scoring Method.- Accessing the Open PHACTS Discovery Platform with workflow tools.- Quantitative Prioritization of Tool Compounds for Phenotypic Screening.- A Quantitative Systems Pharmacology Approach to Infer Pathways Involved in Complex Disease Phenotypes.- Phenotype-based High-content Screening using Fluorescent Chemical Bioprobes: Lipid Droplets and Glucose Uptake Quantification in Live Cells.- Developing High-throughput Electrophysiological Assays for Phenotypic Screening.- Testing Susceptibility of Patient Derived Organoid Cultures to Therapies: Pharmacotyping.- Techniques to Enable 1536-well Phenotypic Screening.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |